Circulating microRNA as a biomarker in brain cancer
| Funding period: 2015 - 2017
Related publications (3)
Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab
Tali Siegal, Hanna Charbit, Iddo Paldor, Bracha Zelikovitch, Tamar Canello, Arriel Benis, Michael L Wong, Andrew P Morokoff, Andrew H Kaye, Iris Lavon
OBJECTIVE Bevacizumab is an antiangiogenic agent under investigation for use in patients with high-grade glioma. It produces a hig..
MicroRNA as potential biomarkers in Glioblastoma
Zammam Areeb, Stanley S Stylli, Rachel Koldej, David S Ritchie, Tali Siegal, Andrew P Morokoff, Andrew H Kaye, Rodney B Luwor
Glioblastoma is the most aggressive and lethal tumour of the central nervous system and as such the identification of reliable pro..
Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme
Iwan E Bennett, Hui Guo, Nicole Kountouri, Giovanna M D'abaco, Christopher M Hovens, Bradford A Moffat, Patricia Desmond, Katharine Drummond, Andrew H Kaye, Andrew P Morokoff
We investigated the correlation between the circulating and imaging biomarkers of tumour vascularity, and examined whether they ar..